The 2026 American dyslipidemia guideline now endorses the PREVENT equations to guide lipid-lowering therapy in primary prevention in adults. Lipid-lowering therapy can be considered with a 10-year ...

The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...

Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, has been associated with lack of response to first-line therapy in the Care ...

Doctors of Meenakshi Mission Hospital has successfully used monoclonal antibody therapy to treat Anti-Glomerular Basement Membrane disease, helping a patient recover kidney function and come off ...

The study published on March 11 shows that children with severe E. coli infections receive significantly less protective antibodies before birth.

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

Monoclonal antibodies are among the most widely used biologic medicines, with applications ranging from cancer treatment to autoimmune disease therapy. However, during manufacturing, storage, or ...

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical lifespan. What it often takes to achieve that level of longevity, however, is ...

Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 ...

While the strategies didn’t lower NT-proBNP after PCI in acute MI patients, they may suggest a way forward for intervening early.

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...